Results 51 to 60 of about 3,182,211 (266)

Recent advances in the anti-HCV mechanisms of interferon

open access: yesActa Pharmaceutica Sinica B, 2014
Interferon (IFN) in combination with ribavirin has been the standard of care (SOC) for chronic hepatitis C for the past few decades. Although the current SOC lacks the desired efficacy, and 4 new direct-acting antiviral agents have been recently approved,
Menghao Huang   +2 more
semanticscholar   +1 more source

Evaluation of a New Anti-HCV-Assay Kit for Anti-HCV Screening in Early Childhood.

open access: yesThe Tohoku Journal of Experimental Medicine, 1999
Sera of 20 children falsely identified as positive for hepatitis C virus antibody (Anti-HCV) by a second generation anti-HCV-assay kit (Imucheck-HCV Ab "Kokusai") were re-tested using a new third generation anti-HCV-assay kit (Imucheck x F-HCV C50 Ab "Kokusai").
K, Sugiyama   +8 more
openaire   +3 more sources

Hepatitis C among Hospital Personnel and Patients at a General Hospital in Kafr Elsheikh Governorate, Egypt

open access: yesJournal of High Institute of Public Health, 2021
Background: To fight against hepatitis C virus (HCV) epidemic in Egypt, it is crucial to understand the actual HCV situation. Hospitals have been accused as being an epicenter for sustained HCV spread in Egypt.
Rania M. Brakat   +3 more
doaj   +1 more source

The Practicability of the Xpert HCV Viral Load Fingerstick Point-of-Care Assay in Primary Care Settings

open access: yesViruses, 2021
Linkage to care presents one obstacle toward eliminating HCV, and the current two-step pathway (anti-HCV, followed by HCV-RNA testing) results in the loss of patients.
David Petroff   +5 more
doaj   +1 more source

HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia.

open access: yesJournal of Infection in Developing Countries, 2013
INTRODUCTION This study investigated the seroprevalence of hepatitis B virus surface antigen (HBsAg), antibody against hepatitis C virus (anti-HCV), antibody against human immunodeficiency virus type 1/2 (anti-HIV 1/2), and antibody against Treponema ...
S. Dayan   +7 more
semanticscholar   +1 more source

A hepatitis C virus (HCV) fertőzés pathogenesise: a genetikai és az immunológiai tényezők, valamint az oxidativ stress szerepe és a kórokozó virus sajátosságai, különös tekintettel a HCV-okozta betegségekben és a tünetmentes virushordozó állapotban = Pathogenesis of hepatitis C virus (HCV) infection: the role of the genetic and immunological factors, the oxidative stress and the viral features in the HCV-related diseases and in the symptomfree virus carriers [PDF]

open access: yes, 2009
Genetikai, immunológiai és környezeti tényezők potenciális szerepe krónikus hepatitis C virus (HCV) infekcióban: összehasonlitó vizsgálatok aktiv HCV hepatitises betegekben és tünetmentes "egészséges" virushordozókban. 1.
Berki, Timea   +5 more
core  

Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge [PDF]

open access: yes, 2016
End-stage liver disease caused by hepatitis C virus (HCV) infection is a major indication for liver transplantation. However, immediately after transplantation the liver graft of viremic patients universally becomes infected by circulating virus ...
Baumert, Thomas F.   +12 more
core   +3 more sources

Göz Kuruluğu Şikayetiyle Başvuran Sjögren Sendromlu Hastalarda Anti-HCV Seroprevalansının Araştırılması

open access: yesHitit Medical Journal, 2023
Amaç: Sjögren Sendromu (SS) esas olarak ekzokrin bezleri tutan ve tükrük ve gözyaşı bezlerinin tutulumu sonucu ağız ve gözlerin kuruluğu ile karakterize sistemik otoimmün bir hastalıktır.
Esmeray Mutlu Yılmaz, Gokhan Ozgur
doaj   +1 more source

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy [PDF]

open access: yes, 2006
BACKGROUND: The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated.
Ancarani, Fausto   +14 more
core   +2 more sources

Kan vericilerde HBsAg, anti-HCV, anti-HIV ve Sifilis seroprevalansı

open access: yesSakarya Tıp Dergisi, 2011
Bu çalışmada Afyon Kocatepe Üniversitesi Tıp Fakültesi Kan Merkezi'ne başvuran donörlerde HBsAg, anti-HCV, anti-HIV 1/2 ve RPR seroprevalansının tespiti ve oranların yıllara ve cinsiyete göre dağılımının belirlenmesi amaçlanmıştır.
Mustafa Altındiş   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy